Definium Therapeutics, Inc. · NASDAQ:DFTX

Sullivan Mark received 62,500 Definium Therapeutics, Inc. shares as an award (Form 4)

Traded Aug 12, 2026 · Filed Aug 12, 2026

On Aug 12, 2026, Sullivan Mark (Chief Legal Officer) received 62,500 Definium Therapeutics, Inc. shares as an award, leaving 383,071 shares. Filed Aug 12, 2026 (Form 4).

Awarded
62,500 shares
Holding after
383,071 shares
Trading plan
No
Role
Chief Legal Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 12, 2026Common SharesAward62,500383,071Direct

Source

View original at SEC

Related